EPISODE · May 11, 2026 · 4 MIN
MFN Agreements, Heart Failure Evidence, and JCA Timelines
Episode 6 — 11 May 2026 Marcus and Sara examine the Trump administration's voluntary MFN pricing agreements with major pharma companies and discuss the HTA implications of WhiteSwell's DELTA-HF heart failure trial results. They debate the challenges of evidence strategy when major policy developments move at inconsistent paces. Hosted by Marcus and Sara. Outcomes Analytica Podcast — Daily briefings on HEOR, HTA strategy and the evidence access landscape. outcomes-analytica.no
Embed this episode
Ready to play
MFN Agreements, Heart Failure Evidence, and JCA Timelines
No transcript for this episode yet
Similar Episodes
No similar episodes found.